HT
QNCX icon

HAP Trading’s Quince Therapeutics QNCX Stock Holding History

HAP Trading’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-66
Closed -$357K – 2665
2021
Q4 		$357K Sell
66
-19
-22% -$116K 0.01% 810
2021
Q3 		$262K Buy
85
+24
+39% +$382K 0.01% 932
2021
Q2 		$227K Buy
61
+2
+3% +$16.8K 0.01% 957
2021
Q1 		$250K Buy
+59
New +$425K 0.01% 695

Other funds holding QNCX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HAP Trading's QNCX Position: Q4 2021 in Review

HAP Trading sold out of Quince Therapeutics (QNCX) in Q4 2021, closing a stake of 59 shares — an estimated $360K sold.

HAP Trading first reported a position in QNCX in Q3 2021 and held it in 1 quarter. The position peaked at $1.09M in Q3 2021. 97 funds tracked by Wall St. Rank hold QNCX as of Q4 2021.

  • HAP Trading reported no remaining Quince Therapeutics position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 59 Quince Therapeutics shares in Q4 2021, an estimated $360K.
  • HAP Trading first reported a position in Quince Therapeutics in Q3 2021 and held it in 1 quarter.
  • HAP Trading's Quince Therapeutics position peaked at $1.09M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Quince Therapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.